Barcelona

• A study to investigate the safety, pharmacokinetics, pharmacodynamics, and immunogenicity of a CD19/CD20 T-cell engager in participants with … Pending
  2025-522932-15-00 3 Systemic Lupus Erythematosus
• A Study of SGT-003 Gene Therapy in Duchenne Muscular Dystrophy Pending
  2025-522949-22-00 5 Duchenne muscular dystrophy
• An extension study to investigate the long-term safety and tolerability of itepekimab in adult participants with inadequately controlled chr … Pending
  2025-522983-33-00 5 Chronic rhinosinusitis with nasal polyps
• A clinical study of MK-1045 in people with non-Hodgkin lymphoma (MK-1045-008) Pending
  2025-523005-15-00 9 Non-Hodgkin Lymphoma
• Phase Ib Dose-Ranging Study of the Safety, PK, PD & Efficacy of the Activin Signaling Inhibitor HS235 vs placebo added to background therapy … Pending
  2025-523010-89-00 3 Pulmonary arterial hypertension
• A Randomized, Placebo-controlled, Parallel Phase 2a Dose-ranging Study to Investigate the Efficacy, Safety, and Tolerability of Topical HT-0 … Pending
  2025-523058-16-00 4 Skin Toxicities Associated with Epidermal Growth Factor Receptor Inhib
• Adductor canal and IPACK (infiltration between the popliteal artery and the capsule of the knee) blocks versus genicular nerves block for to … Pending
  2025-523071-34-00 6 Knee Osteoarthritis
• STUDY TO FIND OUT WHETHER A SHORTER ANTIBIOTIC TREATMENT (7 DAYS) IS AS EFFECTIVE AND SAFE AS THE USUAL ONE (14 DAYS) IN PATIENTS WITH AN IN … Pending
  2025-523120-53-00 11 Graft pyelonephritis in kidney transplant recipients
• A study to learn if fenfluramine hydrochloride is safe and works in people with Rett syndrome Pending
  2025-523157-34-00 5 Rett syndrome
• Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors Pending
  2025-523232-39-00 1 Advanced Solid Tumors
• A Phase 3 extension study to assess the long-term safety and efficacy of remibrutinib in adult participants with moderate to severe hidraden … Pending
  2025-523259-72-00 5 Hidradenitis Suppurativa (HS)
• HELIOS: Long-term study of DISC-1459 (or Bitopertin) in patients with Erythropoietic Protoporphyria (EPP) or X-Linked Protoporphyria (XLP). Pending
  2025-523275-27-00 5 X-Linked Protoporphyria (XLP)
• A clinical trial to learn more about the effects of DJI136 in people with extensive-stage small cell lung cancer Pending
  2025-523276-23-00 7 Extensive stage small cell lung cancer
• Phase IV, single-center, randomized, crossover clinical trial to validate the use of gadopiclenol versus gadobutrol in the evaluation of mag … Pending
  2025-523278-18-00 6 Perianal fistula associated with Crohn's disease
• Brain imaging to understand early changes in dementia related diseases Pending
  2025-523284-37-00 4 Dementia
• A trial to learn how well AZD0120 works and how safe it is in people with relapsed or refractory multiple myeloma. Pending
  2025-523285-25-00 5 Relapsed or Refractory Multiple Myeloma
• Study of Tirabrutinib vs Rituximab/Temozolomide for Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL) Pending
  2025-523389-26-00 5 Relapsed/refractory primary central nervous system lymphoma
• Multi-centre Phase 1/2 study testing LB-208 for adults with relapsed/refractory AML or high-risk MDS Pending
  2025-523396-38-00 9 Relapse or refractory (r/r) acute myeloid leukaemia (AML) and r/r high
• A First-In-Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination with Cemiplimab Works in Adult Participan … Pending
  2025-523399-22-00 7 Melanoma
• Safety and Efficacy of VX-828/Deutivacaftor Combination Therapy With and Without Tezacaftor in Subjects With Cystic Fibrosis Pending
  2025-523400-72-00 4 Cystic fibrosis
• PODOMOUNT-Basket, a study to test whether BI 764198 helps adults and adolescents with different types of kidney disease Pending
  2025-523425-17-00 4 Proteinuric kidney diseases
• An efficacy and safety study of cenegermin ophthalmic solution compared with vehicle in the treatment of PCED Pending
  2025-523443-35-00 5 Persistent Corneal Epithelial Defect (PCED)
• A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or … Pending
  2025-523461-17-01 5 LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER
• A Study of S241656 in Patients With KRAS, BRAF and Other Selected RAS/MAPK Mutation-Positive Malignancies Pending
  2025-523474-16-00 7 Malignancies with Documented KRAS, BRAF and Other Selected RAS/MAPK Mu

Showing 193–216 of 3,391 trials